[]SML Genetree and TEMA Ricerca Announce Exclusive Distribution Agreement for Italy

SML Genetree and TEMA Ricerca Announce Exclusive Distribution Agreement for Italy


SML Genetree announced they have recently signed an exclusive distribution agreement with TEMA Ricerca Srl., based in Castenaso, Bologna, Italy. TEMA Ricerca has been appointed as the exclusive distributor in Italy for SML Genetree’s Ezplex® Real-time PCR and NGS kits. TEMA Ricera is a well-known Italy-based provider of clinical laboratory and cutting edge life science research products to laboratories, hospitals, and industry for over 30 years.


“We are excited to announce our new partnership with TEMA Ricerca for the distribution of SML Genetree’s molecular diagnostic products. This is a valued partnership with our commitment to providing customers quality in vitro diagnostic products and exceptional service,” said Jihoon Ahn, CEO of SML Genetree.


About TEMA Ricerca Srl  

TEMA RICERCA is a private Italian firm founded in the 1990’s with the mission of supplying cutting-edge solutions for the life science and IVD diagnostic sectors. They offer products, instruments and expertise for biomedical research (life science) and diagnostics laboratories in public health, university, CRO, pharmaceutical, public and private hospital facilities.

For more information, please visit: https://www.temaricerca.com/


About SML Genetree

SML Genetree is a global developer of multiplex clinical molecular diagnostic tests who is dedicated to improving healthcare by developing, manufacturing, and distributing highly accurate molecular test solutions. The company received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its COVID-19 PCR test, the Ezplex® SARS-CoV-2 G Real-Time PCR Kit and has obtained CE marking for several of its Ezplex® kits.


For more information, please visit https://www.smlgenetree.com/


SANTA CLARA, CA, April 12, 2022